These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10066843)

  • 1. Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome.
    Pantano P; Caramia F; Bozzao L; Dieler C; von Kummer R
    Stroke; 1999 Mar; 30(3):502-7. PubMed ID: 10066843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
    Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR;
    Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic core and hypoperfusion volumes predict infarct size in SWIFT PRIME.
    Albers GW; Goyal M; Jahan R; Bonafe A; Diener HC; Levy EI; Pereira VM; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Baxter BW; Devlin TG; Lopes DK; Reddy VK; de Rochemont Rdu M; Singer OC; Bammer R; Saver JL
    Ann Neurol; 2016 Jan; 79(1):76-89. PubMed ID: 26476022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.
    Trouillas P; Nighoghossian N; Getenet JC; Riche G; Neuschwander P; Froment JC; Turjman F; Jin JX; Malicier D; Fournier G; Gabry AL; Ledoux X; Derex L; Berthezène Y; Adeleine P; Xie J; Ffrench P; Dechavanne M
    Stroke; 1996 May; 27(5):882-90. PubMed ID: 8623108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.
    Kim SH; Saver JL
    Stroke; 2015 Jan; 46(1):132-6. PubMed ID: 25424482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point.
    Ebinger M; Christensen S; De Silva DA; Parsons MW; Levi CR; Butcher KS; Bladin CF; Barber PA; Donnan GA; Davis SM;
    Stroke; 2009 Apr; 40(4):1353-8. PubMed ID: 19246703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
    Trouillas P; Nighoghossian N; Derex L; Adeleine P; Honnorat J; Neuschwander P; Riche G; Getenet JC; Li W; Froment JC; Turjman F; Malicier D; Fournier G; Gabry AL; Ledoux X; Berthezène Y; Ffrench P; Dechavanne M
    Stroke; 1998 Dec; 29(12):2529-40. PubMed ID: 9836764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke.
    Heiss WD; Grond M; Thiel A; von Stockhausen HM; Rudolf J; Ghaemi M; Löttgen J; Stenzel C; Pawlik G
    J Cereb Blood Flow Metab; 1998 Dec; 18(12):1298-307. PubMed ID: 9850142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wake-up stroke: thrombolysis reduces ischemic lesion volume and neurological deficit.
    Furlanis G; Ajčević M; Buoite Stella A; Cillotto T; Caruso P; Ridolfi M; Cova MA; Naccarato M; Manganotti P
    J Neurol; 2020 Mar; 267(3):666-673. PubMed ID: 31720820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort.
    Fiorelli M; Bastianello S; von Kummer R; del Zoppo GJ; Larrue V; Lesaffre E; Ringleb AP; Lorenzano S; Manelfe C; Bozzao L
    Stroke; 1999 Nov; 30(11):2280-4. PubMed ID: 10548658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome.
    Lev MH; Segal AZ; Farkas J; Hossain ST; Putman C; Hunter GJ; Budzik R; Harris GJ; Buonanno FS; Ezzeddine MA; Chang Y; Koroshetz WJ; Gonzalez RG; Schwamm LH
    Stroke; 2001 Sep; 32(9):2021-8. PubMed ID: 11546891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT perfusion identifies increased salvage of tissue in patients receiving intravenous recombinant tissue plasminogen activator within 3 hours of stroke onset.
    Silvennoinen HM; Hamberg LM; Lindsberg PJ; Valanne L; Hunter GJ
    AJNR Am J Neuroradiol; 2008 Jun; 29(6):1118-23. PubMed ID: 18403559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model.
    Andersen M; Overgaard K; Meden P; Boysen G; Choi SC
    Stroke; 1999 Jul; 30(7):1464-71. PubMed ID: 10390324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.